Supermax Corp. Bhd.

Supermax Corp. Bhd.

MMYX:SUPERMX
0.44
MYR
+0.00
(-1.14%)
Nov 26Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.29
0.3
- -
0.33
0.39
0.46
0.64
2.21
0.85
0.26
0.21
0.25
- -
0.24
Basic EPS, GAAP
0.03
0.04
- -
0.02
0.03
0.04
0.16
1.18
0.23
-0.04
-0.06
-0.05
- -
-0.05
Free Cash Flow per Basic Share
-0.01
-0.01
- -
- -
0.03
0.04
0.34
0.98
-0.03
-0.22
-0.25
-0.14
- -
-0.09
Dividend per Share
0.01
0.01
- -
0.01
0.02
0.01
- -
0.14
0.21
0.04
0.03
- -
- -
- -
Book Value per Share
0.27
0.3
- -
0.31
0.3
0.33
0.47
1.47
1.52
1.49
1.45
1.33
1.26
1.26
Tangible Book Value per Share
0.26
0.29
- -
0.3
0.29
0.33
0.46
1.47
1.52
1.49
1.45
1.33
1.26
1.26
Basic Weighted Avg Shares
3,496
3,502
1,348
3,450
3,384
3,323
3,313
3,245
3,173
3,164
3,118
3,083
- -
3,083
Sales/Revenue/Turnover
1,004
1,053
- -
1,127
1,304
1,538
2,132
7,164
2,687
821
646
780
737
737
Operating Margin (%)
12.61
13.93
- -
9.56
13.02
12.13
32.46
70
42.43
-17.28
-37.38
-29.3
-29.52
-29.52
Depreciation Expense
28
- -
- -
41
42
45
62
69
74
85
68
- -
- -
- -
Net Income, GAAP
96
127
- -
67
107
123
525
3,817
719
-141
-176
-145
-154
-154
Effective Tax Rate (%)
25.8
17.07
- -
34.88
31.97
28.6
21.38
21.71
28.54
- -
- -
- -
- -
- -
Profit Margin (%)
9.52
12.06
- -
5.96
8.18
8
24.62
53.27
26.75
-17.16
-27.18
-18.6
-20.88
-20.88
Working Capital
214
154
- -
68
6
34
407
3,285
3,180
2,259
1,613
1,008
783
783
LT Debt
146
99
- -
107
62
61
102
64
53
19
22
14
13
13
Total Equity
944
1,036
- -
1,070
1,023
1,134
1,551
4,894
5,032
4,692
4,467
4,093
3,862
3,862
Return on Invested Capital (%)
7.43
8.77
- -
9.17
7.72
8.76
30.2
96.16
13.94
- -
- -
- -
- -
- -
Return on Capital (%)
8.12
9.67
- -
9.38
7.56
9.19
31.01
105.43
13.14
- -
- -
- -
- -
- -
Return on Common Equity (%)
10.37
12.81
- -
12.59
10.26
11.53
39.57
121.4
14.94
-2.98
-3.88
-3.4
-3.88
-3.88

Capital Structure

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
ST Debt
144
146
201
LT Borrowings
17
17
13
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,057
3,057
3,057
Market Capitalization
1,024
932
825

Working Capital

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'26
Total Current Assets
1,085
991
1,183
Cash, Cash Equivalents & STI
757
638
612
Accounts Receivable, Net
72
70
74
Inventories
149
189
250
Total Current Liabilities
320
336
400
Payables & Accruals
- -
- -
- -
ST Debt
144
146
201
Deferred Revenue
- -
- -
- -

Growth Rates

MYR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-4.55%
-5.65%
Free Cash Flow
- -
76.61%
-37.4%
Net Income, GAAP
- -
-37.48%
6.12%
Sales/Revenue/Turnover
- -
-27.61%
-5.45%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
178
146
143
180
646
2025
225
199
204
152
780
2026
206
187
127
217
737

Quarterly Earnings Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
-0.01
- -
-0.05
-0.06
2025
-0.02
- -
-0.01
-0.02
-0.05
2026
-0.04
-0.02
-0.01
0.03
- -

Quarterly Dividends Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
- -
- -
- -
0.03
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Chee Keong Tan
Full Time Employees
1,409
Sector
Distribution services
Industry
Medical distributors
Address
Lot 38, Putra Industrial Park Sungai Buloh Malaysia 47000
IPO Date
Jul 13, 2000
Business
Supermax Corporation Berhad operates as an investment holding company with primary focus on the manufacturing, global distribution, and marketing of healthcare and eyecare products from its Malaysian base. The company produces a comprehensive range of medical gloves, including both natural rubber and nitrile latex varieties, alongside specialized personal protective equipment. Furthermore, Supermax has established itself in the eyecare sector, engaging in the manufacturing, distribution, and marketing of contact lenses, a venture initiated in 2014 with its dedicated facility commencing operations in 2016. The group's operational scope extends to the trading, importing, and worldwide distribution of its glove products, supported by energy-efficient biomass systems within its facilities. Supermax also maintains interests in property holding activities through its subsidiaries. As a prominent own-brand manufacturer, Supermax markets its offerings under well-recognized labels such as Supermax, Aurelia, and Maxter, catering to a global clientele of laboratories, hospitals, pharmacists, doctors, and surgeons. With eleven manufacturing facilities in Malaysia and an annual glove production capacity reaching up to 24 billion pieces, the company fulfills approximately 12% of the global demand for latex examination gloves. Its extensive international presence spans over 160 countries across the Americas, Europe, the Middle East, Asia, and the South Pacific, reinforced by eight distribution centers and corporate offices located in key global markets, alongside collaborations with over 1,200 independent distributors. In recent times, the company has faced challenges, including import bans by the United States in October 2021 and contract terminations by Canada in November 2021, both citing allegations of forced labor. Subsequently, Norway's sovereign wealth fund placed Supermax under observation in June 2022 due to similar human rights concerns. In response, Supermax initiated plans for an advanced manufacturing facility in Texas, US, which began production in January 2025, and is investing heavily in automation, robotics, and AI to enhance efficiency and reduce reliance on manual labor. The company, founded in 1987, maintains its headquarters in Sungai Buloh, Malaysia.